DaVita
DVA
#1816
Rank
S$14.73 B
Marketcap
S$229.51
Share price
1.26%
Change (1 day)
40.07%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): S$16.08

According to DaVita's latest financial reports the company's current EPS (TTM) is S$15.98. In 2025 the company made an earnings per share (EPS) of S$12.96 a decrease over its 2024 EPS that were of S$14.12.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$16.0824.09%
2025S$12.96-8.25%
2024S$14.1244.94%
2023S$9.7427.26%
2022S$7.66-35.56%
2021S$11.8844.1%
2020S$8.2519.7%
2019S$6.89540.48%
2018S$1.08-76.07%
2017S$4.49-19.31%
2016S$5.57242.52%
2015S$1.63-62.87%
2014S$4.3813.43%
2013S$3.868.45%
2012S$3.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$31.79 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$15.58-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$33.44 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.71-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA